• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.

作者信息

Steinberg Benjamin A

机构信息

Division of Cardiovascular Medicine, University of Utah Health Sciences Center, 30 North Mario Capecchi Drive, Salt Lake City, UT 84112, USA.

出版信息

Eur Heart J. 2024 Jun 28;45(24):2130-2132. doi: 10.1093/eurheartj/ehae347.

DOI:10.1093/eurheartj/ehae347
PMID:38848112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11492272/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb82/11492272/4d79b5914361/ehae347_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb82/11492272/4d79b5914361/ehae347_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb82/11492272/4d79b5914361/ehae347_ga.jpg

相似文献

1
Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.心房颤动与长期心血管结局：聚焦整体情况
Eur Heart J. 2024 Jun 28;45(24):2130-2132. doi: 10.1093/eurheartj/ehae347.
2
The relationship between history of thyroid diseases and risk of in-hospital cardiovascular outcomes in patients with atrial fibrillation: Findings From the CCC-AF (Improving Care for Cardiovascular Disease in China-Atrial Fibrillation) Project.甲状腺疾病史与心房颤动患者住院心血管结局风险之间的关系：中国心血管病医疗质量改善项目（CCC-AF）的研究结果
Med Clin (Barc). 2021 May 7;156(9):421-427. doi: 10.1016/j.medcli.2020.04.048. Epub 2020 Jul 16.
3
Acute management of atrial fibrillation with rapid ventricular response.伴有快速心室反应的心房颤动的急性处理
Br J Hosp Med (Lond). 2019 Jun 2;80(6):C82-C85. doi: 10.12968/hmed.2019.80.6.C82.
4
The Canadian Cardiovascular Society Atrial Fibrillation Guidelines Program: A Look Back Over the Last 10 Years and a Look Forward.加拿大心血管学会心房颤动指南项目：回顾过去十年并展望未来
Can J Cardiol. 2020 Dec;36(12):1839-1842. doi: 10.1016/j.cjca.2020.10.001. Epub 2020 Oct 7.
5
Management of atrial fibrillation.心房颤动的管理。
Med Clin North Am. 2015 Jul;99(4):781-94. doi: 10.1016/j.mcna.2015.02.007. Epub 2015 Apr 11.
6
Ischemic stroke and atrial fibrillation--a deadly serious combination.缺血性中风与心房颤动——一种极其致命的组合。
Cerebrovasc Dis. 2011;32(5):461-2. doi: 10.1159/000332030. Epub 2011 Oct 14.
7
The heart and the brain: cardiovascular risk factors, atrial fibrillation, and dementia.心脏与大脑：心血管危险因素、心房颤动与痴呆
Eur Heart J. 2019 Jul 21;40(28):2271-2275. doi: 10.1093/eurheartj/ehz508.
8
Atrial fibrillation. Prevent stroke, stop symptoms.心房颤动。预防中风，缓解症状。
Mayo Clin Health Lett. 2012 Jun;30(6):1-3.
9
Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.口服抗凝控制与肾功能对接受经皮冠状动脉介入治疗的房颤患者发生主要不良事件的协同影响：来自AFCAS注册研究的见解
Clin Res Cardiol. 2017 Jun;106(6):420-427. doi: 10.1007/s00392-016-1071-0. Epub 2017 Jan 11.
10
Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.房颤最佳抗凝状态下电复律的心血管事件：多中心分析
Yonsei Med J. 2015 Nov;56(6):1552-8. doi: 10.3349/ymj.2015.56.6.1552.

本文引用的文献

1
Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.心房颤动：诊断时的年龄、心血管事件的发生和死亡率。
Eur Heart J. 2024 Jun 28;45(24):2119-2129. doi: 10.1093/eurheartj/ehae216.
2
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.心力衰竭指南指导药物治疗的抗心律失常作用及其在预防心源性猝死中的作用：从β受体阻滞剂到钠-葡萄糖协同转运蛋白2抑制剂及其他。
J Clin Med. 2024 Feb 26;13(5):1316. doi: 10.3390/jcm13051316.
3
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.
在 II 期临床试验中接受 Asundexian 治疗的患者的出血结局。
J Am Coll Cardiol. 2024 Feb 13;83(6):669-678. doi: 10.1016/j.jacc.2023.12.004.
4
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南：心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
5
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.直接口服抗凝剂预防器械检测到的心房颤动患者卒中：NOAH-AFNET 6 和 ARTESiA 试验的研究水平荟萃分析。
Circulation. 2024 Mar 26;149(13):981-988. doi: 10.1161/CIRCULATIONAHA.123.067512. Epub 2023 Nov 12.
6
Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.心律失常负担与伴有阵发性心房颤动和心脏植入式电子设备患者心血管结局的风险。
Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010304. doi: 10.1161/CIRCEP.121.010304. Epub 2022 Jan 28.
7
Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.心房颤动筛查：美国预防服务工作组推荐声明。
JAMA. 2022 Jan 25;327(4):360-367. doi: 10.1001/jama.2021.23732.
8
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes.早发性心房颤动与心肌病和心律失常基因罕见变异的患病率。
JAMA Cardiol. 2021 Dec 1;6(12):1371-1379. doi: 10.1001/jamacardio.2021.3370.
9
Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program.心房颤动临床实践中患者报告的结局及后续管理：犹他州mEVAL AF项目的结果
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3187-3195. doi: 10.1111/jce.14795. Epub 2020 Nov 11.
10
Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters.重新审视心房颤动的心率控制与节律控制——时机很重要。
N Engl J Med. 2020 Oct 1;383(14):1383-1384. doi: 10.1056/NEJMe2027180. Epub 2020 Aug 29.